Grail (GRAL) Receivables - Other (2024 - 2026)
Grail's (GRAL) quarterly Receivables - Other came in at $300000.0 in Q4 2025, up 50.0% YoY from $200000.0 in Q4 2024, and down 25.0% on a QoQ basis from $400000.0 in Q3 2025.
Grail (GRAL) Receivables - Other (2024 - 2026) Analysis & Trends
Grail (GRAL) has 2 years of Receivables - Other data on file, last reported at $300000.0 in Q4 2025.
- Quarterly Receivables - Other rose 50.0% year-over-year to $300000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $300000.0 (up 50.0% YoY) and the FY2025 annual result came in at $300000.0, up 50.0% from the prior year.
- Receivables - Other declined to $300000.0 in Q4 2025, from $400000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $400000.0 in Q3 2025 to a low of $200000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Grail | 3.56 Bn | 2.70 Bn | 21.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 400,000.00 |
| Jun 30, 2026 | 400,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |